The US Food and Drug Administration (FDA) has approved Lembaz (adrabetadex) for the treatment of infantile-Niemann Pick disease type C (NPC). NPC is a complex lysosomal storage disorder mainly characterized by the accumulation of unesterified cholesterol in lysosomes....













International Rett Syndrome Foundation Works to Advance Research and Support Families
CheckRare 79 minutes ago